School of Medicine


Showing 1-50 of 292 Results

  • Raag Airan

    Raag Airan

    Assistant Professor of Radiology (Neuroimaging and Neurointervention) and, by courtesy, of Psychiatry and Behavioral Sciences and of Materials Science and Engineering

    Current Research and Scholarly InterestsOur goal is to develop and clinically implement new technologies for high-precision and noninvasive intervention upon the nervous system. Every few millimeters of the brain is functionally distinct, and different parts of the brain may have counteracting responses to therapy. To better match our therapies to neuroscience, we develop techniques that allow intervention upon only the right part of the nervous system at the right time, using technologies like focused ultrasound and nanotechnology.

  • Richard Barth

    Richard Barth

    Professor of Radiology (Pediatric Radiology) and, by courtesy, of Obstetrics and Gynecology (Maternal Fetal Medicine)

    Current Research and Scholarly InterestsMagnetic Resonance Imaging and Sonographic diagnosis of fetal anomalies.
    Focus interest in the diagnosis and conservative (non-surgical and minimal radiation) management of congenital broncho pulmonary malformations.
    Imaging of appendicitis in children.
    Sonography of the pediatric testis.

  • Christopher Beaulieu M.D., Ph.D.

    Christopher Beaulieu M.D., Ph.D.

    Professor of Radiology (Musculoskeletal Imaging)

    Current Research and Scholarly InterestsInformatics and image processing techniques that provide infrastructure for diagnosis in musculoskeletal imaging. Decision support for improving accuracy of bone tumor diagnosis. Improved methods for MRI in the musculoskeletal system.

  • Hans-Christoph Becker, MD, FSABI, FSCCT

    Hans-Christoph Becker, MD, FSABI, FSCCT

    Clinical Professor, Radiology

    Current Research and Scholarly InterestsMyocardial bridges (MB) with associated upfront atherosclerotic lesions are common findings on coronary computed tomography angiography (CTA). Abnormal septal wall motion in exercise echocardiography (EE) may to be associated with MB. Intravascular ultrasound (IVUS) is considered the gold standard for the detection of MB. We investigate whether CTA is comparable to IVUS for the assessment of MB and upstream plaques in symptomatic patients with suspicion for MB raised by EE.

  • Corinne Beinat

    Corinne Beinat

    Assistant Professor of Radiology (Molecular Imaging Program at Stanford)

    Current Research and Scholarly InterestsThe focus of my research is to develop novel imaging and treatment strategies to detect and better manage cancer. This approach relies first on the identification and validation of molecular targets and biomarkers that are linked with underlying the underlying biology driving the initiation and progression of cancers. We then develop novel small molecule based radiotracers to monitor fundamental molecular and cellular processes occurring in living subjects using positron emission tomography (PET) with the goal of improving cancer diagnosis and management. We additionally develop novel peptide based theragnostic agents for stratification of patients with high receptor expression, treatment with targeted radionuclide therapy, and subsequent monitoring of treatment response. Our overall goal is to develop multiple clinically translatable strategies to improve cancer diagnosis, management, and outcomes.

  • Sandip Biswal, MD

    Sandip Biswal, MD

    Adjunct Clinical Professor, Radiology

    Current Research and Scholarly InterestsThe management of individuals suffering from chronic pain is unfortunately limited by poor diagnostic tests and therapies. Our research group is interested in 'imaging pain' by using novel imaging techniques to study peripheral nociception and inflammation with the goal of accurately identifying the location of pain generators. We are developing new approaches with positron emission tomography (PET) and magnetic resonance imaging (MRI) (PET/MRI) and are currently in clinical trials.

  • Rachelle Bitton

    Rachelle Bitton

    Clinical Assistant Professor, Radiology

    Current Research and Scholarly InterestsDeveloping interventional techniques and patient specific models in MR image guided High Intensity Focused Ultrasound (HIFU). PRF thermometry monitoring for ablative applications in cancer trans-cranial functional neurosurgery to treat essential tremor and Parkinson's disease.

    Treatment efficacy and clinical outcomes analysis in multi-center trials of MR guided interventions to treat desmoid tumors, uterine leiomyomas, and osseous metastasis.
    Photoacoustic imaging of microvasculature.

  • Francis Blankenberg

    Francis Blankenberg

    Associate Professor of Radiology (Pediatric Radiology) and, by courtesy, of Pediatrics

    Current Research and Scholarly InterestsStudies on apoptotic cell death in vivo using the H MRS phenomenon.

  • Fernando E Boada

    Fernando E Boada

    Professor of Radiology (Radiological Sciences Laboratory)

    BioFernando Boada is a Professor of Radiology and Associate Chair for Basic Science Translational Research at Stanford University Medical School. [1] He joined Stanford in 2021 after being Professor of Radiology, Psychiatry and Neurosurgery at New York University Medical School and the Director of the Center for Advanced Imaging Innovation and Research. [1] Prior to joining NYU in 2012, Dr. Boada directed the MR Research Center (MRRC) at the University of Pittsburgh for ten years. [1] His research efforts have been focused on the development of novel MRI techniques for addressing open neuroimaging questions in a translational setting.

  • Robert Downey Boutin

    Robert Downey Boutin

    Clinical Professor, Radiology

    BioDr. Boutin works clinically as a musculoskeletal radiologist interpreting a broad array of diagnostic imaging examinations, most frequently MRI, CT, sonography, and radiography.

    The clinical focus for Dr. Boutin is MRI of joints, bones, and muscles, as well as adding value to routine radiology exams by translating advancements from fields of artificial intelligence and imaging informatics.

    These advancements include enhancing routine imaging exams to help promote physical function, quality of life, and health span in our patients. Because the worldwide population of people > 60 years of age is projected to double by 2050, there is a crucial need for improvements in the accurate and efficient management of derangements associated with biological aging, including osteoporosis, sarcopenia, and visceral adiposity.

    Dr. Boutin is a leader in the field of musculoskeletal imaging. He has served as the Chair of the Musculoskeletal Imaging Program Committee for the largest medical meeting in the world (RSNA) and is the President of the Society of Academic Bone Radiologists. Core professional values include an emphasis on outstanding quality, compassion, safety, and integrity.

    Dr. Boutin was introduced to Orthopaedics at an early age by his father and older brother -- both orthopaedists. After earning undergraduate and graduate degrees at Stanford University, Dr. Boutin completed advanced fellowship training in Musculoskeletal Imaging at the University of California, San Diego, and worked on the faculty at Harvard Medical School.

    Dr. Boutin is dedicated to excellence in musculoskeletal imaging. Dr. Boutin has written over 100 peer-reviewed articles and textbook chapters. He has also served as Guest Editor for 2 volumes of the 'Orthopaedic Clinics of North America', and volumes of ‘Seminars in Musculoskeletal Radiology’. Dr. Boutin also has served for many years as a Peer Reviewer for premier radiology journals.

    Dr. Boutin is a popular invited lecturer for Continuing Medical Education Courses, such as those at the annual meetings of the 'Radiological Society of North America', the 'International Skeletal Society', the 'Arthroscopy Association of North America', the 'American Academy of Orthopaedic Surgeons', and the 'International Society for Magnetic Resonance in Medicine'. He is also a repeat lecturer at the prestigious Orthopaedic Imaging course in Davos, Switzerland.

  • Sujatha Buddhe

    Sujatha Buddhe

    Clinical Professor, Pediatrics - Cardiology
    Clinical Associate Professor (By courtesy), Radiology - Pediatric Radiology

    BioDr. Buddhe earned her medical degree from the Osmania Medical College, Hyderabad, India. She completed her pediatrics residency and chief residency at the Brookdale University Hospital and Medical Center, NY and pediatric cardiology fellowship at the Children's Hospital of Michigan. Her advanced fellowship training in pediatric cardiac non-invasive imaging was completed at the Columbia University College of Physicians and Surgeons, Morgan Stanley Children's Hospital in New York. She earned her Masters degree in Clinical research and statistical analysis at the University of Michigan, Ann Arbor. She worked at Seattle Children's Hospital, University of Washington for almost ten years where she served as the Director of Non-invasive Imaging research and the Co-Director of cardiac MRI program. Her research interests include echocardiography and Cardiac MRI.

  • Stephanie Tzu-Ying Chang

    Stephanie Tzu-Ying Chang

    Assistant Professor of Radiology

    BioDr. Stephanie Chang is a physician in the Department of Radiology at VA Palo Alto and Assistant Professor in Radiology at Stanford University School of Medicine.

    Dr. Chang’s research program aims to utilize state-of-the-art diagnostic technology to non-invasively detect abdominal diseases that predispose or lead to cancer since the most beneficial and cost-effective cancer imaging occurs in the screening/early detection phase.

    Currently, metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) are leading worldwide causes of end-stage liver disease and liver cancer (hepatocellular carcinoma, HCC). To determine the optimal multimodality screening and diagnostic pathway, Dr. Chang leads prospective research studies at VA Palo Alto comparing blood-based and imaging-based diagnostic tests – the Fibrosis-4 (FIB-4) Index, the Enhanced Liver Fibrosis (ELF) test, vibration controlled transient elastography (VCTE), ultrasound point shear wave elastography (US pSWE), and magnetic resonance imaging (MRI) elastography – among high-risk veterans with obesity and/or type 2 diabetes to compare relative performance and costs/benefits.

    To improve detection of hepatocellular carcinoma (HCC) among patients with end-stage liver disease (cirrhosis), Dr. Chang also serves as a member of the VA National Radiology Working Group and radiology local site investigator at VA Palo Alto for a multicenter VA research study CSP #2023 PREventing liver cancer Mortality through Imaging with Ultrasound vs. MRI (PREMIUM STUDY) comparing US and MRI to determine optimal screening strategies for hepatocellular carcinoma.

    While MRI has the overall highest sensitivity and specificity for many diseases and contains additional biological/prognostic information not obtainable via other imaging methods, the utility of MRI as a powerful non-invasive screening tool has been hampered by its limitations in access, time, and cost. Dr. Chang is interested in significantly shortening MRI exam times to accelerate MRI throughput, decrease patient discomfort, and reduce costs. To accomplish this goal, Dr. Chang is interested in improving pulse sequences to shorten MRI acquisition times while maintaining or increasing diagnostic quality. In addition, Dr. Chang is interested in novel MRI techniques to improve disease detection and staging.

  • Akshay Chaudhari

    Akshay Chaudhari

    Assistant Professor (Research) of Radiology (Integrative Biomedical Imaging Informatics at Stanford) and of Biomedical Data Science

    Current Research and Scholarly InterestsDr. Chaudhari is interested in the application of artificial intelligence techniques to all aspects of medical imaging, including automated schedule and reading prioritization, image reconstruction, quantitative analysis, and prediction of patient outcomes. His interests focus on the development and evaluation new self-supervised and representation learning techniques for multi-modal deep learning in healthcare using vision, language, and medical records data

  • Jeremy Dahl

    Jeremy Dahl

    Associate Professor of Radiology (Pediatric Radiology)
    On Partial Leave from 07/01/2024 To 06/30/2025

    Current Research and Scholarly InterestsUltrasonic beamforming, imaging methods, systems, and devices.

  • Erpeng Dai

    Erpeng Dai

    Instructor, Radiology

    BioDr. Erpeng Dai's research interest is focused on advanced neuro MRI technique development and application. Previously, he has developed a series of novel techniques for high-resolution and fast diffusion MRI (dMRI). Currently, he is mainly working on distortion-free dMRI, advanced diffusion encoding, and brain microstructure and connectivity studies.

  • Heike Daldrup-Link

    Heike Daldrup-Link

    Professor of Radiology (General Radiology) and, by courtesy, of Pediatrics (Hematology/Oncology)

    Current Research and Scholarly InterestsAs a physician-scientist involved in the care of pediatric patients and developing novel pediatric molecular imaging technologies, my goal is to link the fields of nanotechnology and medical imaging towards more efficient diagnoses and image-guided therapies. Our research team develops novel imaging techniques for improved cancer diagnosis, for image-guided-drug delivery and for in vivo monitoring of cell therapies in children and young adults.

  • Bruce Daniel

    Bruce Daniel

    Professor of Radiology (Body Imaging) and, by courtesy, of Bioengineering

    Current Research and Scholarly Interests1. MRI of Breast Cancer, particularly new techniques. Currently being explored are techniques including ultra high spatial resolution MRI and contrast-agent-free detection of breast tumors.

    2. MRI-guided interventions, especially MRI-compatible remote manipulation and haptics

    3. Medical Mixed Reality. Currently being explored are methods of fusing patients and their images to potentially improve breast conserving surgery, and other conditions.

  • Guido A. Davidzon

    Guido A. Davidzon

    Clinical Associate Professor, Radiology - Rad/Nuclear Medicine

    BioDr. Guido Alejandro Davidzon is a Clinical Associate Professor of Nuclear Medicine and Molecular Imaging at the Stanford School of Medicine. He serves as the Director of Nuclear Cardiology at Stanford Health Care and is the Acting Chair of both the Clinical Radiation Safety Committee and the Radioactive Drug Research Committee.

    Dr. Davidzon’s research focuses on advancing diagnostic and therapeutic approaches to improve clinical outcomes in prevalent diseases. His work emphasizes the clinical translation and evaluation of radioligands for applications in oncology, neurodegeneration, cardiology, and pain imaging, as well as the integration of machine learning techniques into clinical care.

  • Johannes Hugo Decker

    Johannes Hugo Decker

    Clinical Assistant Professor, Radiology

    BioHugo Decker is part of the Diagnostic Radiology resident call of 2018-2022.
    He received his BS in Biological Sciences at Stanford in 2008.
    He completed his MSTP training at Weill Cornell Medical College in 2017.
    He completed his Medical internship at Santa Clara Valley Medical Center in 2018.

  • Wendy DeMartini

    Wendy DeMartini

    Professor of Radiology (Breast Imaging)

    BioDr. Wendy DeMartini is a Professor in the Department of Radiology at Stanford University School of Medicine. She currently serves as the Associate Chair for Clinical Faculty Affairs in the Department of Radiology, and is the past Division Chief of Breast Imaging. Her work is focused upon high quality patient care, clinical research and education.

    Dr. DeMartini completed her fellowship in Breast Imaging at the University of Washington School of Medicine in Seattle, Washington. She then served as Breast Imaging faculty at the University of Washington where she became Associate Professor and Associate Director of Clinical Services, and at the University of Wisconsin where she became Professor and Chief of Breast Imaging.

    Dr. DeMartini has more than 100 research presentations, abstracts/publications, review articles or book chapters. Her research is directed toward the appropriate evidence-based use of imaging tests to optimize the detection and evaluation of breast cancer. She has served as an investigator on several studies of breast MRI funded by the National Cancer Institute and by the American College of Radiology Imaging Network (ACRIN). Particular research topics have included the development of a pilot tool for predicting the probability of malignancy of breast MRI lesions, assessment of the impact of background parenchymal enhancement (BPE) on breast MRI accuracy, and evaluation of utilization patterns of breast MRI and other emerging technologies.  She also served as the Editor-in-Chief of the Journal of Breast Imaging from 2023 to 2024.

    Dr. DeMartini is a highly sought-after educator. She lectures on a broad spectrum of breast imaging topics nationally and internationally, including in the Americas, Europe, Australasia and Africa. She is the past Co-Director of the American College of Radiology (ACR) Education Center Breast MRI with Biopsy Course. Dr. DeMartini is an active member of many professional organizations and committees, including in the Radiologic Society of North America, the American College of Radiology and the Society of Breast Imaging (SBI). She was elected as an SBI Fellow in 2009 and served as President of the SBI in 2017-2018.

  • Utkan Demirci

    Utkan Demirci

    Professor of Radiology (Diagnostic Sciences Laboratory) and, by courtesy, of Electrical Engineering

    BioDr. Utkan Demirci, UofM’99, Stanford’01’05’05, is a Professor of Radiology (with tenure) and of Electrical Engineering (by courtesy) at the Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, where he leads a productive researcher group. Utkan is a tenured professor at Stanford University School of Medicine. Prior to joining Stanford in 2014, he held the position of Associate Professor at the Brigham and Women’s Hospital-Harvard Medical School and also served at the Harvard-MIT Health Sciences and Technology division. Over the past decade, his research group has focused on the early detection of cancer and has made significant contributions to the development of microfluidic platforms for sorting rare cells and exosomes and point-of-care bio-sensing technologies.

    Dr. Demirci leads a productive and impactful research group focused on addressing problems from the clinic with innovations including cell sorter for IVF, optical technologies for detecting viruses, portable point of care technologies for diagnostics in global health, smart robots in vivo, extracellular vesicle based early detection approaches for cancer. He is an elected fellow of the American Institute of Medical and Biological Engineering and The Academy for Radiology & Biomedical Imaging Research Distinguished Investigator.

    He has published over 250 peer-reviewed articles, 300 abstracts and proceedings, 24 book chapters and editorials, and 7 edited books. He also serves on the editorial board of various journals. He holds 15 patents (11 of which are translated into broadly used biomedical products) and has co-founded multiple successful companies. Dr. Demirci's pioneering work in microfluidics and cell sorting has resulted in CE certified and FDA approved devices used in over 500,000 clinical cases serving patients globally.

  • Joseph M. DeSimone

    Joseph M. DeSimone

    Sanjiv Sam Gambhir Professor of Translational Medicine, Professor of Chemical Engineering and, by courtesy, of Chemistry, of Materials Science and Engineering, and of Operations, Information and Technology at the Graduate School of Business

    BioJoseph M. DeSimone is the Sanjiv Sam Gambhir Professor of Translational Medicine and Chemical Engineering at Stanford University. He holds appointments in the Departments of Radiology and Chemical Engineering with courtesy appointments in the Department of Chemistry and in Stanford’s Graduate School of Business.

    The DeSimone laboratory's research efforts are focused on developing innovative, interdisciplinary solutions to complex problems centered around advanced polymer 3D fabrication methods. In Chemical Engineering and Materials Science, the lab is pursuing new capabilities in digital 3D printing, as well as the synthesis of new polymers for use in advanced additive technologies. In Translational Medicine, research is focused on exploiting 3D digital fabrication tools to engineer new vaccine platforms, enhanced drug delivery approaches, and improved medical devices for numerous conditions, with a current major focus in pediatrics. Complementing these research areas, the DeSimone group has a third focus in Entrepreneurship, Digital Transformation, and Manufacturing.

    Before joining Stanford in 2020, DeSimone was a professor of chemistry at the University of North Carolina at Chapel Hill and of chemical engineering at North Carolina State University. He is also Co-founder, Board Chair, and former CEO (2014 - 2019) of the additive manufacturing company, Carbon. DeSimone is responsible for numerous breakthroughs in his career in areas including green chemistry, medical devices, nanomedicine, and 3D printing. He has published over 350 scientific articles and is a named inventor on over 200 issued patents. Additionally, he has mentored 80 students through Ph.D. completion in his career, half of whom are women and members of underrepresented groups in STEM.

    In 2016 DeSimone was recognized by President Barack Obama with the National Medal of Technology and Innovation, the highest U.S. honor for achievement and leadership in advancing technological progress. He has received numerous other major awards in his career, including the U.S. Presidential Green Chemistry Challenge Award (1997); the American Chemical Society Award for Creative Invention (2005); the Lemelson-MIT Prize (2008); the NIH Director’s Pioneer Award (2009); the AAAS Mentor Award (2010); the Heinz Award for Technology, the Economy and Employment (2017); the Wilhelm Exner Medal (2019); the EY Entrepreneur of the Year Award (2019 U.S. Overall National Winner); and the Harvey Prize in Science and Technology (2020). He is one of only 25 individuals elected to all three branches of the U.S. National Academies (Sciences, Medicine, Engineering). DeSimone received his B.S. in Chemistry in 1986 from Ursinus College and his Ph.D. in Chemistry in 1990 from Virginia Tech.